Using the back of the arm as a Wegovy injection site

The back of the upper arm (triceps area) is a licensed Wegovy injection site, confirmed in the summary of product characteristics.
Rotating between sites (abdomen, thigh and upper arm) helps prevent injection-site reactions and localised discomfort.
Subcutaneous injections go into the fatty tissue just beneath the skin; the triceps area typically carries enough for a successful shot.
Self-injecting into the back of the arm is possible but physically harder than the abdomen or thigh — a carer or healthcare professional can assist.

The back of the upper arm is one of three licensed injection sites for Wegovy (semaglutide): alongside the abdomen and the thigh, it is explicitly approved in the Wegovy SmPC for subcutaneous administration. That said, reaching the back of the arm solo is genuinely awkward, and many people find it easier with a second pair of hands. These are prescription-only medicines reviewed individually by a clinician before dispensing — the right injection technique matters, and this page covers everything the evidence and official guidance say about this particular site.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Step by step: injecting Wegovy into the back of the upper arm

Step 1, choose the right spot on your arm

The target area is the back of the upper arm, roughly midway between the shoulder and the elbow, in the soft tissue over the triceps. Avoid the bony tip of the shoulder, the elbow crease, and any areas that feel firm or knotted. The skin there needs to pinch into a fold roughly 2–3 cm wide; if it does not, the area may be too lean for a comfortable subcutaneous injection and the abdomen or thigh would be a better choice that day.

Rotate within the upper arm itself (slightly left, slightly right, slightly higher or lower from the previous shot) so you are never placing one injection directly on top of a recent one. Scar tissue and skin thickening from repeated same-spot dosing can slow absorption and cause unnecessary discomfort. Your Patient Information Leaflet maps this out; if anything is unclear, the clinical team is there to help.

It is worth acknowledging that if you are new to self-injecting, the back of the arm can feel intimidating. That is entirely normal. Most people find the abdomen the easiest starting point while they build confidence, then try the arm when a friend or partner is around to assist.

Step 2, prepare cleanly and position carefully

Wash your hands thoroughly. Let the pen reach roughly room temperature if you have taken it straight from the fridge, injecting cold semaglutide is not dangerous but can sting more than necessary. Check the pen window shows the correct fill and colour before you begin.

For a solo attempt, sitting in front of a mirror at an angle is the most practical approach: it lets you see the site and line up the pen without twisting sharply. A wall-mirror works, as does propping a phone to use the camera. Remove the cap, pinch the skin gently if needed, and place the pen flat against the skin at a 90-degree angle. Press firmly and hold for the full count the leaflet specifies (typically around 10 seconds) to ensure the full dose is delivered before you withdraw.

If someone else is administering the injection, the process is considerably simpler: you sit or stand comfortably with the arm relaxed at your side, and they position the pen on the pinched skin just as they would for a thigh injection. The broader guidance on arm injection technique for Wegovy covers the anatomical landmarks in more detail.

Step 3 (aftercare and what to watch for

Once the pen is withdrawn, press lightly with a clean finger or gauze) do not rub, as rubbing can irritate the site. A small red mark or mild bruising is common and settles within a day or two. If the site becomes swollen, warm and tender beyond 48 hours, or if you notice any lump that persists for more than a week, mention it to your prescriber at the next contact point.

Injection-site reactions are among the more frequently reported side effects with semaglutide, per the NHS medicines information for semaglutide. They are usually mild and resolve on their own. Rotating consistently is the most effective preventive measure. If you are injecting into the arm regularly and notice persistent lumps or thickened skin, move to the abdomen or thigh for a few weeks to let the tissue recover.

Dispose of the used pen in a sharps container immediately after use, never in household waste. Keep spare pens refrigerated at 2–8°C and consult the leaflet for the exact period a pen may be kept at room temperature once removed from the fridge.

How site choice fits into the bigger clinical picture

The injection site you use does not change the dose, but absorption rates can differ slightly between sites, studies with other subcutaneous medicines suggest the abdomen tends to give the most consistent uptake. This is not unique to Wegovy and is rarely clinically significant at weekly dosing intervals, but it is a reason not to arbitrarily switch sites immediately before a clinical review if you want a consistent baseline.

For a broader look at how Wegovy works and what the trial data show, the Wegovy treatment overview sets out the evidence clearly. If you are wondering about weight returning after stopping Wegovy, that is a separate question with its own clinical reasoning worth reading before any changes. And if back discomfort has been on your mind since starting treatment, it is worth reading about whether Wegovy can cause back pain before drawing conclusions, including the more specific question of how back pain and Wegovy interact for people already mid-treatment.

Wegovy is a prescription-only medicine; a prescriber reviews the full picture (your medical history, current dose, any side effects) before every supply. If you are considering starting treatment or have questions about your current site technique, speaking to our prescribers is the natural next step. There is no obligation and no charge for the consultation itself.

For context on the cost of private treatment, the Wegovy cost and access guide explains what a legitimate prescription price covers and what to be cautious of.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions